PDCD1 and Hepatitis: Hence, we conducted a retrospective study to explore the effects of HBV load on anti-PD-1 in combination with an antiangiogenic therapy and the rate of HBV reactivation and hepatitis during a combined anti-PD-1 and antiangiogenic treatment.